Performance
Trailing returns
| 1 day |
| -0.78% | |||
| 1 week | +0.32% |
| |||
| 4 week | +6.93% |
| |||
| 3 month | +10.49% |
| |||
| YTD | +17.19% |
| |||
| 1 year | +30.36% |
| |||
| 3 years* | +17.08% |
| |||
| 5 years* | +5.68% |
| |||
| *annualized | |||||
| Best 3 month return | +26.78% | |
| Worst 3 month return | -28.82% |
Morningstar statistics
Morningstar category: Large Value
| Return | Risk | Rating | |
| 3 years | Average | Average |
 
|
| 5 years | Above Average | Average |
|
| 10 years | Above Average | Average |
|
| Overall | Above Average | Average |
|
Morningstar style Learn more
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
Key statistics
| Total assets | 41.87B | |
| Front load | - | |
| Deferred load | - | |
| Expense ratio | 0.35% | |
| Management fee | - | |
| Fund family | Vanguard |
Asset allocation
| Cash | 3.05% | |
| Stocks | 96.94% | |
| Bonds | 0.00% | |
| Other | 0.00% |
Purchase information
| Initial | $3,000 | |
| Additional | $100 | |
| IRA Initial | $3,000 |
34.35-0.08(-0.23%)
May 23, 4:00PM EDT
Overall Morningstar RatingTM
Description
The investment seeks long-term capital appreciation and income. The fund invests mainly in large- and mid-capitalization companies whose stocks are considered by an advisor to be undervalued. Undervalued stocks are generally those that are out of favor with investors and that the advisor feels are trading at prices that are below average in relation to measures such as earnings and book value. These stocks often have above-average dividend yields. The fund uses multiple investment advisors.
Fund filings (PDF) »
Fund filings (PDF) »
Asset managers:
James Troyer (Started: Feb 28, 2006)
Michael Roach (Started: Feb 27, 2012)
Jeff Fahrenbruch (Started: Feb 27, 2013)
David Ganucheau (Started: Feb 27, 2013)
James Barrow (Started: Jun 24, 1985)
George Davis, Jr. (Started: Dec 11, 2003)
Sheldon Lieberman (Started: Dec 11, 2003)
Lewis Sanders (Started: Jan 13, 2010)
John Mahedy (Started: Jan 13, 2010)
Christopher Blake (Started: Jan 8, 2007)
Jeffrey Shaw (Started: Jan 4, 2006)
James Stetler (Started: Feb 27, 2012)
Andrew Lacey (Started: Jan 8, 2007)
James Troyer (Started: Feb 28, 2006)
Michael Roach (Started: Feb 27, 2012)
Jeff Fahrenbruch (Started: Feb 27, 2013)
David Ganucheau (Started: Feb 27, 2013)
James Barrow (Started: Jun 24, 1985)
George Davis, Jr. (Started: Dec 11, 2003)
Sheldon Lieberman (Started: Dec 11, 2003)
Lewis Sanders (Started: Jan 13, 2010)
John Mahedy (Started: Jan 13, 2010)
Christopher Blake (Started: Jan 8, 2007)
Jeffrey Shaw (Started: Jan 4, 2006)
James Stetler (Started: Feb 27, 2012)
Andrew Lacey (Started: Jan 8, 2007)
Risk
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | 1.83 | -1.09 | -0.17 | 0.75 | |
| Beta* | 0.97 | 1.03 | 1.02 | 1.01 | |
| Mean annual return | 1.46 | 1.05 | 0.57 | 0.79 | |
| R-squared* | 94.91 | 98.44 | 98.41 | 95.60 | |
| Standard deviation | 10.14 | 15.64 | 19.41 | 15.15 | |
| Sharpe ratio | 1.71 | 0.80 | 0.34 | 0.52 | |
| * Against standard index | |||||
Top 10 holdings
| Security | Net Assets | |
| Pfizer Inc (PFE) | 3.14% | |
| Philip Morris International, Inc. (PM) | 2.85% | |
| Johnson & Johnson (JNJ) | 2.61% | |
| American Express Co (AXP) | 2.55% | |
| JPMorgan Chase & Co (JPM) | 2.47% | |
| Microsoft Corporation (MSFT) | 2.29% | |
| Wells Fargo & Co (WFC) | 2.24% | |
| Baxter International Inc. (BAX) | 2.22% | |
| Phillips 66 (PSX) | 2.10% | |
| Medtronic, Inc. (MDT) | 2.05% |